Mastery EAQ Ch. 30

A  Desmopressin

B  Octreotide

C  Corticotropin

D  Somatropin

A  Octreotide

B  Desmopressin

C  Somatropin

D  Vasopressin

A  “You can take the dose immediately when you remember it.”

B  “If it is almost time for your next dose, take a double dose of the drug at that time.”

C  “You should consult your primary health care provider immediately.”

D  “Skip the missed dose and resume your usual dosage schedule.”

A  Cosyntropin

B  Vasopressin

C  Desmopressin

D  Somatropin

A  Abdominal stress

B  Bleeding gums

C  Vertigo

D  Drowsiness

A  “Do not administer the drug to the patient.”

B  “Heat the medicine before administration.”

C  “Keep the bottle in warm water before administration.”

D  “Shake the medication before administration.”

A  Encourage vigorous exercise.

B  Monitor blood glucose levels closely.

C  Evaluate the patient for limping.

D  Monitor fluid status.

A  Administering the vasopressin intravenously

B  Monitoring the patient in an intensive care unit

C  Obtaining liver and renal function tests

D  Co-administering carbamazepine

A  Bleeding gums

B  Abdominal cramps

C  Excessive thirst

D  Limping

A  Low blood pressure, Blood glucose elevation, Headache, Low urine output

B  Nausea, Blood glucose elevation, Headache, Low urine output

C  Headache, Low urine output, Low blood pressure, Nausea

D  Nausea, Blood glucose elevation, Headache, Low blood pressure

A  Somatropin intramuscular

B  Octreotide subcutaneous

C  Vasopressin nasal spray

D  Desmopressin intravenously

A  Electrocardiogram (ECG)

B  Renal panel

C  Liver enzymes

D  Blood glucose

A  Previous somatropin injection site tender to touch.

B  Radiology report identifies no fracture with closed growth plates.

C  Growth percentile has increased from the previous annual physical.

D  Reports episodic muscle pain during the past year.

A  Obtain baseline weight and height measurements

B  Review the frequency with the health care provider

C  Review current laboratory values for blood glucose

D  Calculate the dosage with the pharmacist or another nurse

A  Inquire about abdominal discomfort

B  Assess the patient for headaches

C  Monitor for signs of infiltration

D  Notice increase in body temperature

A  Increased urination, Thirst

B  Edema of the extremities, Elevated blood pressure

C  Weight gain, Edema of the extremities

D  Elevated blood pressure, Weight gain

A  Watch the IV site closely for infiltration.

B  Measure the patient’s urine output regularly.

C  Assess for signs of dehydration.

D  Make a note of the fluid intake.

A  Esophageal varices and a history of type 2 diabetes

B  Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

C  Acromegaly and a serum creatinine level of 5.0 mg/dL

D  Small-bowel fistula and having an acute asthma attack

A  1. Clear the nasal passages.
2. Give half a spray in each nostril.
3. Place the spray nozzle in the nostril.
4. Prime the pump by pressing down four times.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

B  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

C  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Monitor the level of drug left in the pump.
6. Replace the cap on the bottle.

D  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Replace the cap on the bottle.
5. Give half a spray in each nostril.
6. Monitor the level of drug left in the pump.

A  Patient D: VIP; severe diarrhea and flushing; renal impairment

B  Patient A: esophageal varices; type 1 diabetes

C  Patient C: VIP; life-threatening hypotension; diarrhea and flushing

D  Patient B: carcinoid tumor; taking ciprofloxacin

A  Joint pain, Fatigue

B  Diarrhea, Flushing

C  Headache, Joint pain

D  Fatigue, Headache

A  A higher dose of medication is required for treatment.

B  The patient is stable and needs reassurance.

C  The medication is not effective for this condition.

D  The patient needs to adjust fluid intake.

A  Priming the pump each week

B  Administering half the dose in each nostril

C  Inhaling the medication into the airway

D  Storing the pump at room temperature

A  “Do you feel very thirsty lately?”
“How many times do you urinate in a day?”

B  “Is there any change in the color of your sputum?”
“Do you have excessive bleeding due to minor injuries?”

C  “Do you have excessive bleeding due to minor injuries?”
“Is there any change in the color of your urine?”

D  “Is there any change in the color of your urine?”
“Is there any change in the color of your sputum?”

A  Weight, Skin turgor, Visual acuity

B  Motor skills, Visual acuity, Skin turgor

C  Height, Weight, Motor skills

D  Skin turgor, Height, Visual acuity

A  Priming the nasal pump once a week

B  Pressing down on the pump two times to prime it

C  Pressing the pump once to spray a 10-mcg dose

D  Replacing the cap on the pump after the procedure

A  Hypothyroidism

B  Hyperglycemia

C  Hypercalciuria

D  Hypertension

A  “Apply the drug preparation topically to the nasal membranes.”

B  “Shake the drug preparation thoroughly before use.”

C  “Inhale the drug preparation by spraying into the nostrils.”

D  “Dilute the drug preparation before administration.”

A  Oozing blood

B  Abundant, diluted urine

C  Watery diarrhea

D  Loss of consciousness

A  Cachexia and closed growth plates

B  Acute bronchitis with laryngitis

C  Bilateral metastatic breast cancer

D  Human immunodeficiency virus (HIV) infection

A  A 10-year-old of short stature who has severe asthma

B  A 7-year-old diagnosed with growth hormone deficiency

C  A 17-year-old who is 5 feet tall

D  An 8-year-old with a pituitary tumor

A  Somatropin and glucocorticoids

B  Vasopressin and demeclocycline

C  Vasopressin and carbamazepine

D  Desmopressin and carbamazepine

A  Seizures

B  Edema

C  Heartburn

D  Hypoglycemia

A  Orthostatic hypotension

B  Hyponatremia

C  Hypokalemia

D  Hyperglycemia

A  Fludrocortisone

B  Cyclosporine

C  Ciprofloxacin

D  Glucocorticoids

A  Diabetes insipidus, Seizure, Type I von Willebrand

B  Seizure, Asthma, Cardiovascular disease

C  Asthma, Diabetes insipidus, Type I von Willebrand

D  Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

A  Reduces fat levels

B  Decreases fluid retention

C  Decreases growth

D  Reduces weight loss

A  Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

B  Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

C  Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

D  Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

A  Norepinephrine

B  Thioridazine

C  Acetaminophen

D  Carbamazepine

A  Weight, Blood pressure, Blood glucose levels

B  Liver enzyme levels, Blood glucose levels, Renal function studies

C  Renal function studies, Liver enzyme levels, Blood pressure

D  Liver enzyme levels, Renal function studies, Weight

A  Arthralgia, Hypercalciuria, Constipation

B  Dyspnea, Constipation, Hypercalciuria

C  Constipation, Malaise, Hypercalciuria

D  Malaise, Dyspnea,

A  Inflammation

B  Scar formation

C  Hypotension

D  Edema

A  Produces an additive effect

B  Enhances the effects of desmopressin

C  Causes prolongation of QT interval

D  Reduces the effects of desmopressin

A  Vasopressin

B  Octreotide

C  Somatropin

D  Desmopressin

A  Desmopressin

B  Somatropin

C  Cosyntropin

D  Octreotide

A  Headache

B  Dehydration

C  Polydipsia

D  Polyuria

A  Cosyntropin

B  Thyroid hormone

C  Octreotide

D  Oxytocin

A  Ciprofloxacin

B  Demeclocycline

C  Carbamazepine

D  Cyclosporine

A  Uric acid level

B  Creatinine clearance test

C  Blood glucose level

D  Complete blood count result

A  Luteinizing hormone

B  Somatropin

C  Desmopressin

D  Vasopressin

A  Hypopituitary dwarfism

B  Polydipsia

C  Polyuria

D  Acromegaly

A  Vasopressin

B  Cosyntropin

C  Octreotide

D  Oxytocin

A  Somatostatin

B  Choriomammotropin

C  Somatropin

D  Somatolactin

A  Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

B  Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

C  Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

D  Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

A  Increased urine specific gravity

B  Decreased adrenocorticotropic hormone levels

C  Increased serum albumin levels

D  Relief of pain